Topic: Biotech
On BioTech Nation, Dr. Bjorn Melin from the Argentinian firm BioSidus explains the economic reason which drove Argentina to become #2 worldwide cultivating genetically-modified crops.
Then for the BioIssue of the Week, David Ewing Duncan takes up Malaria.
Dr. Carlos Melo, the Manager of Special Projects for the Argentinian firm BioSidus joins host Dr. Moira Gunn to talk about Transgenic Animals -- in this case, cows which produce milk containing juvenile growth hormone. Also, David Ewing Duncan joins us once again for the Bio-Issue of the Week.
On BioTech Nation, Dr. Moira Gunn speaks with Anne De Groot, the Founder & CEO of EpiVax, about smallpox, botox, and more. And for the BioIssue of the Week, science journalist David Ewing Duncan talks about the personalities of scientists.
Dr. Moria Gunn speaks with Michael Morrissey, Executive Vice President for Drug Discovery at Exelixis, talks about their efforts in discovering new drugs for cancer research. And BioIssue of the Week, science journalist David Ewing Duncan talks about the economics of the biotech industry.
Dr. Moira Gunn talks to the chief of a rural South African village, Chief Advocate Mdutshane, and a South African government scientist, Dr. Makhosandile Rebe, about genetically modified crops in South Africa. And on Bio-Issue of the Week, science journalist David Ewing Duncan reviews former President Clinton's keynote speech. This edition of BioTech Nation was broadcast from the BIO2006 conference in Chicago.
On this edition of Biotech Nation, Dr. Moira Gunn speaks with, Ryan Phelan, the Founder & CEO of DNA Direct. He'll tell us about personal DNA testing in your own home and their commitment to DNA counseling.
In today's world, we routinely implant heart pacemakers and replace knee and hip joints. Are we fast becoming part machine? How far can we go? Find out as Dr. Moira Gunn speaks with Dr. Greg Stock, the Director of UCLA's Program on Medicine, Technology and Society and CEO, Signum Biosciences.
Dr. Moira Gunn speaks with Dr. Corey Goodman, the president and CEO of Renovis, who gives us some perspective on regenerative medicine and the ethics of the scientific community.
As part of the recent BioAgenda Summit 2006, Baroness Susan Greenfield, Director of the Royal Institution of Great Britain, debates Ray Kurzweil, one of America's most prolific inventors and a futuristic thinker in his own right. Their topic? One of the burning questions of our time: Will biotechnology save us? Or hurt us? The answers are nuanced, and they often don't agree. We'll find out how the audience voted -- From help us to hurt us to "It's too early to tell."
Dr. Moira Gunn speaks with Lisa Conte, CEO of Napo Pharmaceuticals, who tells us about their approach to diarrhea, a worldwide health problem few want to talk about, yet it affects everyone from children living with bad water to the common Western condition of Irritable Bowel Syndrome.
